MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
CBUS — Cibus, Inc. Class A Common Stock
NasdaqCibus, Inc. Class A Common Stock
$1.71
+0.08(+4.91%)
- O
- 1.63
- H
- 1.76
- L
- 1.63
- V
- 247.44K
⏱️ End-of-day dataAs of Oct 2, 2026
Chart
About CBUS
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
IndustryAGRICULTURAL CHEMICALS
SectorNot available
IPO DateJul 20, 2017
Employees118
Stock ExchangeNasdaq
Ticker SymbolCBUS
Websitehttps://www.cibus.com
Key Financial Statistics
| Market Cap | $116.17M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $1.09 - $4.19 |
| 52-Week Avg Volume | 391.7K |
| VWAP | $1.70 |
| Transactions | 2,004 |
| Total Recorded Bars | 2,314 days |